Sotera Health Company (NASDAQ:SHC) Receives Average Rating of “Moderate Buy” from Brokerages

Shares of Sotera Health Company (NASDAQ:SHC) have earned an average recommendation of “Moderate Buy” from the eleven analysts that are presently covering the firm, Marketbeat.com reports. Three analysts have rated the stock with a hold recommendation and eight have issued a buy recommendation on the company. The average 12 month price objective among brokers that have issued ratings on the stock in the last year is $20.4286.

SHC has been the topic of several analyst reports. Piper Sandler upgraded Sotera Health from a “neutral” rating to an “overweight” rating and upped their price target for the company from $17.00 to $24.00 in a research report on Friday, January 9th. Citigroup raised their price objective on shares of Sotera Health from $21.00 to $23.00 and gave the company a “buy” rating in a research report on Tuesday, February 24th. Wells Fargo & Company lowered shares of Sotera Health to an “overweight” rating in a report on Thursday, January 8th. Zacks Research cut shares of Sotera Health from a “strong-buy” rating to a “hold” rating in a research note on Friday, January 30th. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Sotera Health in a report on Monday, December 29th.

Insider Activity

In related news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of the stock in a transaction on Friday, March 6th. The stock was sold at an average price of $15.27, for a total value of $152,700,000.00. Following the sale, the director owned 12,735,301 shares in the company, valued at approximately $194,468,046.27. This trade represents a 43.98% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Company insiders own 47.55% of the company’s stock.

Hedge Funds Weigh In On Sotera Health

A number of institutional investors have recently added to or reduced their stakes in the business. Corient Private Wealth LLC boosted its position in shares of Sotera Health by 217.4% during the 4th quarter. Corient Private Wealth LLC now owns 44,342 shares of the company’s stock valued at $773,000 after acquiring an additional 30,373 shares during the last quarter. Pacer Advisors Inc. increased its position in shares of Sotera Health by 38.8% in the fourth quarter. Pacer Advisors Inc. now owns 32,173 shares of the company’s stock worth $568,000 after purchasing an additional 8,993 shares during the last quarter. Kera Capital Partners Inc. purchased a new stake in Sotera Health in the fourth quarter valued at approximately $339,000. Invesco Ltd. lifted its position in Sotera Health by 53.9% during the fourth quarter. Invesco Ltd. now owns 519,695 shares of the company’s stock valued at $9,167,000 after purchasing an additional 182,069 shares during the last quarter. Finally, Mercer Global Advisors Inc. ADV lifted its position in Sotera Health by 325.1% during the fourth quarter. Mercer Global Advisors Inc. ADV now owns 77,150 shares of the company’s stock valued at $1,361,000 after purchasing an additional 59,001 shares during the last quarter. 91.03% of the stock is currently owned by institutional investors.

Sotera Health Trading Up 0.7%

NASDAQ:SHC opened at $13.41 on Monday. Sotera Health has a 1 year low of $9.53 and a 1 year high of $19.85. The stock’s fifty day moving average price is $17.35 and its two-hundred day moving average price is $16.75. The company has a debt-to-equity ratio of 3.66, a current ratio of 2.46 and a quick ratio of 2.24. The company has a market cap of $3.81 billion, a P/E ratio of 49.67 and a beta of 1.84.

Sotera Health (NASDAQ:SHC) last announced its quarterly earnings results on Tuesday, February 24th. The company reported $0.26 earnings per share for the quarter, beating the consensus estimate of $0.24 by $0.02. The company had revenue of $303.44 million during the quarter, compared to analysts’ expectations of $300.68 million. Sotera Health had a return on equity of 42.38% and a net margin of 6.70%.The firm’s quarterly revenue was up 4.6% compared to the same quarter last year. During the same period in the previous year, the business earned $0.21 earnings per share. Sotera Health has set its FY 2026 guidance at 0.930-1.01 EPS. As a group, analysts expect that Sotera Health will post 0.61 EPS for the current year.

About Sotera Health

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.